QIAGEN OmicSoft and Biomedical Knowledge Base

QIAGEN Biomedical KB-HD: data- and analytics-driven drug discovery

May 14, 2024
Ingenuity Pathway Analysis (IPA), currently cited in tens of thousands of publications and used by a large number of biopharmaceutical companies, is backed by QIAGEN Biomedical KB-HD. Accordingly, biomedical relationships knowledge has practically become required for innovative data- and analytics-driven drug discovery. It powers biomedical knowledge graph analysis, artificial intelligence (AI)-driven target identification and many more applications.

In this webinar, we will introduce Biomedical KB-HD and how it allows its users to tackle applications that are not feasible with the Ingenuity Pathway Analysis graphical user interface or can be done faster and with more flexibility programmatically. We will demonstrate queries such as

• Quickly find the shortest connections between genes/proteins/metabolites of interest in the context of specific disease through queries
• Systematically build a network given a short list of genes/proteins/metabolites/chemicals
• Recreate a drug mechanism of action

Related videos

QIAGEN OmicSoft and Biomedical Knowledge Base

Knowledge graphs and more: Analytics-driven drug discovery using advanced biomedical...

1,743 views July 19, 2022

High-quality biomedical relationships knowledge is the cornerstone of modern...

QIAGEN OmicSoft and Biomedical Knowledge Base

QIAGEN OmicSoft trainings- 3 part series - Oct 20 (part 1)

808 views October 26, 2021

In three separate 60-minute trainings, attendees will learn how to use basic...

QIAGEN OmicSoft and Biomedical Knowledge Base

Expression data analysis using QIAGEN Omicsoft Studio - Sep 28 2021

745 views October 01, 2021

In this training, users will learn how to generate downstream outputs such...